The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway

Genes and Development

Volumn 10, Issue 10, 1996, Pages 1219-1232

  Wang, Xin Wei ^a   Vermeulen, Wim ^b   Coursen, Jill D ^a   Gibson, Michael ^a   Lupold, Shawn E ^a   Forrester, Kathleen ^a   Xu, Guowei ^a   Elmore, Lynne ^a   Yeh, Heidi ^a   Hoeijmakers, Jan H J ^b   Harris, Curtis C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

apoptosis; p53; TFIIH; XPB; XPD

Indexed keywords

DNA; DOXORUBICIN; HELICASE; PROTEIN P53;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DIAGNOSIS; DNA REPAIR; ENZYME ISOLATION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; XERODERMA PIGMENTOSUM;

EID: 0001166257     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.10.1219     Document Type: Article

References (96)

1. 1 cell cycle check-points and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. 92: 8493-8497.
2. Bakalkin, G., T. Yakovleva, G. Selivanova, K.P. Magnusson, L. Szekely, E. Kiseleva, G. Klein, L. Terenius, and K.G. Wiman. 1994. p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. Proc. Nad. Acad. Sci. 91: 413-417.
3. Banks, L., G. Matlashewski, and L. Crawford. 1986. Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur. J. Biochem. 159: 529-534.
4. Bayle, J.H., B. Elenbaas, and A.J. Levine. 1995. The carboxy-terminal domain of the p53 protein regulates sequence-specific DNA binding through its nonspecific nucleic acid-binding activity. Proc. Natl. Acad. Sci. 92: 5729-5733.
5. Bazar, L.S. and H.J. Deeg. 1992. Ultraviolet B-induced DNA fragmentation (apoptosis) in activated T-lymphocytes and Jurkat cells is augmented by inhibition of RNA and protein synthesis. Exp. Hematol. 20: 80-86.
6. Bissonnette, R.P., F. Echeverri, A. Mahboubi, and D.R. Green. 1992. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359: 552-554.
7. Bootsma, D. and J.H. Hoeijmakers. 1993. DNA repair. Engagement with transcription. Nature 363: 114-115.
8. Caelles, C., A. Helmberg, and M. Karin. 1994. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370: 220-223.
9. Chen, P.L., Y. Chen, R. Bookstein, and W.H. Lee. 1991. Genetic mechanisms of tumor suppression by the human p53 gene. Science 250: 1576-1580.
10. Cho, Y., S. Gorina, P. Jeffrey, and N.P. Pavletich. 1994. Crystal structure of a p53 tumor suppressor-DNA complex: A framework for understanding how mutations inactivate p53. Science 265: 346-355.
11. Clarke, A.R., C.A. Purdie, D.J. Harrison, R.G. Morris, C.C. Bird, M.L. Hooper, and A.H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852.
12. Cleaver, J.E. 1994. It was a very good year for DNA repair. Cell 76: 1-4.
13. Crook, T., N.J. Marston, E.A. Sara, and K.H. Vousden. 1994. Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell 79: 817-827.
14. Debbas, M. and E. White. 1993. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes & Dev. 7: 546-554.
15. Dittmer, D., S. Pati, G. Zambetti, S. Chu, A.K. Teresky, M. Moore, C. Finlay, and A.J. Levine. 1993. Gain of function mutations in p53. Nature Genet. 4: 42-46.
16. Drapkin, R., J.T. Reardon, A. Ansari, J.C. Huang, L. Zawel, K. Ahn, A. Sancar, and D. Reinberg. 1994. Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II. Nature 368: 769-772.
17. El-Deiry, W.S., S.E. Kern, J.A. Pietenpol, K.W. Kinzler, and B. Vogelstein. 1992. Definition of a consensus binding site for p53. Nature Genet. 1: 45-49.
18. El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.E. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
19. Enari, M., H. Hug, and S. Nagata. 1995. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375: 78-81.
20. Evan, G.I., A.H. Wyllie, C.S. Gilbert, T.D. Littlewood, H. Land, M. Brooks, C.M. Waters, L.Z. Penn, and D.C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128.
21. Feaver, W.J., J.Q. Svejstrup, L. Bardwell, A.J. Bardwell, S. Buratowski, K.D. Gulyas, T.F. Donahue, E.C. Friedberg, and R.D. Kornberg. 1993. Dual roles of a multiprotein complex from S. cerevisiae in transcription and DNA repair. Cell 75: 1379-1387.
22. Feaver, W.J., J.Q. Svejstrup, N.L. Henry, and R.D. Kornberg. 1994. Relationship of CDK-activating kinase and RNA polymerase II CTD kinase TFIIH/TFIIK. Cell 79: 1103-1109.
23. Fields, S. and S.K. Jang. 1990. Presence of a potent transcription activating sequence in the p53 protein. Science 249: 1046-1048.
24. Flejter, W.L., L.D. McDaniel, D. Johns, E.C. Friedberg, and R.A. Schultz. 1992. Correction of xeroderma pigmentosum complementation group D mutant cell phenotypes by chromosome and gene transfer: Involvement of the human ERCC2 DNA repair gene. Proc. Natl. Acad. Sci. 89: 261-265.
25. Foord, O.S., P. Bhattacharya, Z. Reich, and V. Rotter. 1991. A DNA binding domain is contained in the C-terminus of wild type p53 protein. Nucleic Acids Res. 19: 5191-5198.
26. Funk, W.D., D.T. Pak, R.H. Karas, W.E. Wright, and J.W. Shay. 1992. A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell Biol. 12: 2866-2871.
27. Graeber, T.G., C. Osmanian, T. Jacks, D.E. Housman, C.J. Koch, S.W. Lowe, and A.J. Glaccia. 1996. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379: 88-91.
28. Greenblatt, M.S., W.P. Bennett, M. Hollstein, and C.C. Harris. 1994. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res. 54: 4855-4878.
29. Harris, C.C., H. Grady, and D. Svoboda. 1968. Alterations in pancreatic and hepatic ultrastructure following acute cycloheximide intoxication. J. Ultrastruct. Res. 22: 240-251.
30. Haupt, Y., S. Rowan, E. Shaulian, K.H. Vousden, and M. Oren. 1995. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes & Dev. 9: 2170-2183.
31. Hermeking, H. and D. Eick. 1994. Mediation of c-Myc-induced apoptosis by p53. Science 265: 2091-2093.
32. Hollstein, M., D. Sidransky, B. Vogelstein, and C.C. Harris. 1991. p53 mutations in human cancers. Science 253: 49-53.
33. Hupp, T.R. and D.P. Lane. 1994. Allosteric activation of latent p53 tetramers. Curr. Biol. 4: 865-875.
34. Hupp, T.R., D.W. Meek, C.A. Midgley, and D.P. Lane. 1992. Regulation of the specific DNA-binding function of p53. Cell 71: 875-886.
35. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243.
36. Jayaraman, L. and C. Prives. 1995. Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell 81: 1021-1029.
37. Kastan, M.B., Q. Zhan, W.S. El-Deiry, F. Carrier, T. Jacks, W.V. Walsh, B.S. Plunkett, B. Vogelstein, and A.J. Fornace Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in Ataxia-Telangiectasia. Cell 71: 587-597.
38. Kern, S.E., K.W. Kinzler, A. Bruskin, D. Jarosz, P. Friedman, C. Prives, and B. Vogelstein. 1991. Identification of p53 as a sequence-specific DNA-binding protein. Science 252: 1708-1711.
39. Kern, S.E., J.A. Pietenpol, S. Thiagalingam, A. Seymour, K.W. Kinzler, and B. Vogelstein. 1992. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256: 827-830.
40. Kerr, J.F., A.H. Wyllie, and A.R. Currie. 1972. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancel 26: 239-257.
41. Kraemer, K.H., H.G. Coon, R.A. Petinga, S.F. Barrett, A.E. Rahe, and J.H. Robbins. 1975. Genetic heterogeneity in Xeroderma pigmentosum: Complementation groups and their relationship to DNA repair rates. Proc. Natl. Acad. Sci. 72: 59-63.
42. Lane, D.P. 1992. Cancer. p53, guardian of the genome. Nature 358: 15-16.
43. Lee, J.M. and A. Bernstein. 1993. p53 mutations increase resistance to ionizing radiation. Proc. Natl. Acad. Sci. 90: 5742-5746.
44. Lee, S., B. Elenbase, A. Levine, and J. Griffith. 1995. p53 and its 14kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81: 1013-1020.
45. Levine, A.J., J. Momand, and C.A. Finlay. 1991. The p53 tumour suppressor gene. Nature 351: 453-456.
46. Lin, J., J. Chen, B. Elenbaas, and A.J. Levine. 1994. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes & Dev. 8: 1235-1246.
47. Livingstone, L.R., A. White, J. Sprouse, E. Livanos, T. Jacks, and T.D. Tlsty. 1992. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70: 923-935.
48. Los, M., M. Van de Craen, L.C. Penning, H. Schenk, M. Westendorp, P.A. Baeuerle, W. Droge, P.H. Krammer, W. Fiers, and K. Schulze-Osthoff. 1995. Requirement of an ICE/ CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 375: 81-83.
49. Lowe, S.W. and H.E. Ruley. 1993. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes & Dev. 7: 535-545.
50. Lowe, S.W., H.E. Ruley, T. Jacks, and D.E. Housman. 1993a. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967.
51. Lowe, S.W., E.M. Schmitt, S.W. Smith, B.A. Osborne, and T. Jacks. 1993b. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849.
52. Lowe, S.W., S. Bodis, A. McClatchey, L. Remington, H.E. Ruley, D.E. Fisher, D.E. Housman, and T. Jacks. 1994. p53 status and the efficacy of cancer therapy in vivo. Science 266: 807-810.
53. Lu, X. and D.P. Lane. 1993. Differential induction of transcriptionally active p53 following UV or ionizing radiation: Defects in chromosome instability syndromes? Cell 75: 765-778.
54. Martin, S.J. 1993. Protein or RNA synthesis inhibition induces apoptosis of mature human CD4+ T cell blasts. Immunol. Lett. 35: 125-134.
55. Meek, D.W., S. Simon, U. Kikkawa, and W. Eckhart. 1990. The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II. EMBO J. 9: 3253-3260.
56. Miyashita, T. and J.C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299.
57. Miyashita, T., S. Krajewski, M. Krajewska, H.G. Wang, H.K. Lin, D.A. Liebermann, B. Hoffman, and J.C. Reed. 1994. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805.
58. Okamoto, K. and D. Beach. 1994. Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J. 13: 4816-4822.
59. Oltvai, Z.N., C.L. Milliman, and S.J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619.
60. Owen-Schaub, L.B., W. Zhang, J.C. Cusack, L.S. Angelo, S.M. Santee, T. Fujiwara, J.A. Roth, A.B. Deisseroth, W.W. Zhang, E. Kruzel, and R. Radinsky. 1995. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell Biol. 15: 3032-3040.
61. Perry, M.E., J. Piette, J.A. Zawadzki, D. Harvey, and A.J. Levine. 1993. The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc. Natl. Acad. Sci. 90: 11623-11627.
62. Pietenpol, J.A., T. Tokino, S. Thiagalingam, W.S. El-Deiry, K.W. Kinzler, and B. Vogelstein. 1994. Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. 91: 1998-2002.
63. Qin, X.Q., D.M. Livingston, W.G. Kaelin, Jr., and P.D. Adams. 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. 91: 10918-10922.
64. Raff, M.C., B.A. Barres, J.F. Burne, H.S. Coles, Y. Ishizaki, and M.D. Jacobson. 1993. Programmed cell death and the control of cell survival: Lessons from the nervous system. Science 262: 695-700.
65. Rowan, S., R.L. Ludwig, Y. Haupt, S. Bates, X. Lu, M. Oren, and K.H. Vousden. 1996. Specific loss of apoptotic but not cell cycle arrest function in a human tumour derived p53 mutant. EMBO J. 15: 827-838.
66. Roy, R., J.P. Adamcsewski, T. Seroz, W. Vermeulen, J.P. Tassan, L. Schaeffer, E.A. Nigg, J.H.J. Hoeijmakers, and J.M. Egly. 1994a. The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor. Cell 79: 1093-1101.
67. Roy, R., L. Schaeffer, S. Humbert, W. Vermeulen, G. Weeda, and J.M. Egly. 1994b. The DNA-dependent ATPase activity associated with the class II basic transcription factor BTF2/ TFIIH. J. Biol. Chem. 269: 9826-9832.
68. Sabbatini, P., J. Lin, A.J. Levine, and E. White. 1995. Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes & Dev. 9: 2184-2192.
69. Schaeffer, L., R. Roy, S. Humbert, V. Moncollin, W. Vermeulen, J.H. Hoeijmakers, P. Chambon, and J.M. Egly. 1993. DNA-repair helicase: A component of BTF2 (TFIIH) basic transcription factor. Science 260: 58-63.
70. Schaeffer, L., V. Moncollin, R. Roy, A. Staub, M. Mezzina, A. Sarasin, G. Weeda, J.H. Hoeijmakers, and J.M. Egly. 1994. The ERCC2/DNA repair protein is associated with the class II BTF2/TFIIH transcription factor. EMBO J. 13: 2388-2392.
71. Shaw, P., R. Bovey, S. Tardy, R. Sahli, B. Sordat, and J. Costa. 1992. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. 89: 4495-4499.
72. Slingerland, J.M., J.R. Jenkins, and S. Benchimol. 1993. The transforming and suppressor functions of p53 alleles: Effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation. EMBO J. 12: 1029-1037.
73. Stefanini, M., P. Lagomarsini, S. Giliani, T. Nardo, E. Botta, A. Peserico, W.J. Kleijer, A.R. Lehmann, and A. Sarasin. 1993. Genetic heterogeneity of the excision repair defect associated with trichothiodystrophy. Carcinogenesis 14: 1101-1105.
74. Strasser, A., A.W. Harris, T. Jacks, and S. Cory. 1994. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 79: 329-339.
75. Sturzbecher, H.W., R. Brain, C. Addison, K. Rudge, M. Remm, M. Grimaldi, E. Keenan, and J.R. Jenkins. 1992. A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization. Oncogene 7: 1513-1523.
76. Sung, P., V. Bailly, C. Weber, L.H. Thompson, L. Prakash, and S. Prakash. 1993. Human xeroderma pigmentosum group D gene encodes a DNA helicase. Nature 365: 852-855.
77. Svejstrup, J.Q., Z. Wang, W.J. Feaver, X. Wu, D.A. Bushnell, T.F. Donahue, E.C. Friedberg, and R.D. Kornberg. 1995. Different forms of TFIIH for transcription and DNA repair: Holo-TFIIH and a nucleotide excision repairsome. Cell 80: 21-28.
78. Symonds, H., L. Krall, L. Remington, M. Saenz-Robles, S. Lowe, T. Jacks, and T. Van Dyke. 1994. p53-Dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78: 703-711.
79. Takenaka, I., F. Morin, B.R. Seizinger, and N. Kley. 1995. Regulation of the sequence-specific DNA-binding function of p53 by protein kinase C and protein phosphatases. J. Biol. Chem. 270: 5405-5411.
80. Thut, C.J., J.-L. Chen, R. Klemm, and R. Tjian. 1995. p53 transcriptional activation mediated by coactivators TAFii40 and TAFii60. Science 267: 100-104.
81. Vermeulen, W., M. Stefanini, S. Giliani, J.H. Hoeijmakers, and D. Bootsma. 1991. Xeroderma pigmentosum complementation group H falls into complementation group D. Mutat. Res. 255: 201-208.
82. Vermeulen, W., R.J. Scott, S. Rodgers, H.J. Muller, J. Cole, C.F. Arlett, W.J. Kleijer, D. Bootsma, J.H. Hoeijmakers, and G. Weeda. 1994a. Clinical heterogeneity within xeroderma pigmentosum associated with mutations in the DNA repair and transcription gene ERCC3. Am. J. Hum. Genet. 54: 191-200.
83. Vermeulen, W., A.J. van Vuuren, M. Chipoulet, L. Schaeffer, E. Appeldoom, G. Weeda, N.G.J. Jaspers, A. Priestly, C.F. Arlett, A.R. Lehmann, M. Stefanini, M. Mezzina, A. Sarasin, D. Bootsma, J. Egly, and J.H. Hoeijmakers. 1994b. Three unusual repair deficiencies associated with transcription factor BTF2 (TFIIH): Evidence for the existence of a transcription syndrome. Cold Spring Harbor Symp. Quant. Biol. 58: 317-329.
84. Wagner, A.J., J.M. Kokontis, and N. Hay. 1994. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/ cip1. Genes & Dev. 8: 2817-2830.
85. Wang, L., M. Miura, L. Bergeron, H. Zhu, and J. Yuan. 1994. lch-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78: 739-750.
86. Wang, X.W., K. Forrester, H. Yeh, M.A. Feitelson, J.R. Gu, and C.C. Harris. 1994. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc. Natl. Acad. Sci. 91: 2230-2234.
87. Wang, X.W., M.K. Gibson, W. Vermeulen, H. Yeh, K. Forrester, H.W. Sturzbecher, J.H.J. Hoeijmakers, and C.C. Harris. 1995a. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res. 55: 6012-6016.
88. Wang, X.W., H. Yeh, L. Schaeffer, R. Roy, V. Moncollin, J.M. Egly, Z. Wang, E.C. Friedberg, M.K. Evans, B.G. Taffe, V.A. Bohr, J.H. Hoeijmakers, K. Forrester, and C.C. Harris. 1995b. p53 Modulation of TFIIH-associated nucleotide excision repair activity. Nature Genet. 10: 188-195.
89. Wang, Z., J.Q. Svejstrup, W.J. Feaver, X. Wu, R.D. Kornberg, and E.C. Friedberg. 1994. Transcription factor b (TFIIH) is required during nucleotide-excision repair in yeast. Nature 368: 74-76.
90. Weeda, G., R.C. van Ham, W. Vermeulen, D. Bootsma, A.J. van der Eb, and J.H. Hoeijmakers. 1990. A presumed DNA helicase encoded by ERCC-3 is involved in the human repair disorders xeroderma pigmentosum and Cockayne's syndrome. Cell 62: 777-791.
91. Wolkowicz, R., A. Peled, N.B. Elkind, and V. Rotter. 1995. Augmented DNA-binding activity of p53 protein encoded by a carboxyl-terminal alternatively spliced mRNA is blocked by p53 protein encoded by the regularly spliced form. Proc. Natl. Acad. Sci. 92: 6842-6846.
92. Wu, X. and A.J. Levine. 1994. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. 91: 3602-3606.
93. Xiao, H., A. Pearson, B. Coulombe, R. Truant, S. Zhang, J.L. Regier, S.J. Triezenberg, D. Reinberg, O. Flores, C.J. Ingles, et al. 1994. Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol. Cell Biol. 14: 7013-7024.
94. Yin, Y., M.A. Tainsky, F.Z. Bischoff, L.C. Strong, and G.M. Wahl. 1992. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70: 937-948.
95. Yonish-Rouach, E., D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi, and M. Oren. 1991. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352: 345-347.
96. Zhan, Q., K.A. Lord, I. Alamo, Jr., M.C. Hollander, F. Carrier, D. Ron, K.W. Kohn, B. Hoffman, D.A. Liebermann, and A.J. Fornace, Jr.. 1994. The GADD and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol. Cell Biol. 14: 2361-2371.